Skip to content

On this page

Proleukin

aldesleukin

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Proleukin

Proper name

aldesleukin

Licence type

351(a)

BLA number

103293

Applicant

Iovance Biotherapeutics Manufacturing LLC

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
22MILLION INTERNATIONAL UNITS (1.3MG)	For Injection	Intravenous	Single-Dose Vial	Rx	May 5, 1992

Exclusivity

Source: Purple Book

Kind	Expires
Orphan exclusivity	January 9, 2005

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity